Author | Year | Country | Ethnicity | Sample size (case/control) | Source of control | Cancer site and type | Genotype distribution | Genotyping method | P for HWE | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case | Control | |||||||||||||
CC | CT | TT | CC | CT | TT | |||||||||
Jin [10] | 2016 | China | Asian | 246/284 | PB | cervical cancer | 117 | 103 | 26 | 169 | 99 | 16 | MassArray | 0.74 |
Li [9] | 2016 | China | Asian | 1147/1203 | PB | colorectal cancer | 480 | 514 | 153 | 456 | 570 | 177 | TaqMan | 0.959 |
Xia [11] | 2016 | China | Asian | 464/467 | PB | breast cancer | 160 | 156 | 148 | 139 | 212 | 116 | CRS-RFLP | 0.052 |
Hua [17] | 2016 | China | Asian | 1046/1394 | HB | bladder cancer | 431 | 467 | 148 | 573 | 665 | 156 | TaqMan | 0.074 |
Yang [8] | 2015 | China | Asian | 500/500 | HB | gastric cancer | 160 | 252 | 88 | 193 | 244 | 63 | TaqMan | 0.296 |
Verhaegh [16] | 2008 | Netherlands | Caucasian | 177/204 | PB | bladder cancer | 114 | 59 | 4 | 115 | 80 | 9 | PCR-RFLP | 0.288 |
Hu [22] | 2017 | China | Asian | 416/416 | HB | pancreatic cancer | 133 | 200 | 83 | 128 | 196 | 92 | TaqMan | 0.302 |
Guo [23] | 2017 | China | Asian | 362/740 | PB | oral squamous cell carcinoma | 101 | 181 | 80 | 255 | 348 | 137 | BeadChip | 0.342 |
Lin [12] | 2017 | China | Asian | 1005/1020 | HB | breast cancer | 403 | 471 | 131 | 465 | 450 | 105 | SNPscan | 0.801 |
He [21] | 2017 | China | Asian | 193/383 | HB | osteosarcoma | 79 | 102 | 12 | 195 | 165 | 23 | TaqMan | 0.121 |
Hassanzarei [13] | 2017 | Iranian | Asian | 230/240 | PB | breast cancer | 71 | 132 | 27 | 125 | 113 | 2 | PCR-RFLP | 0 |
Li [18] | 2018 | China | Asian | 200/200 | HB | bladder cancer | 51 | 140 | 9 | 84 | 90 | 26 | TaqMan | 0.806 |
Yuan [24] | 2018 | China | Asian | 431/984 | PB | oral squamous cell carcinoma | 186 | 194 | 51 | 488 | 423 | 73 | MassArray | 0.151 |
Cui [14] | 2018 | China | Asian | 1488/1675 | PB | breast cancer | 611 | 692 | 185 | 685 | 773 | 217 | TaqMan | 0.963 |
Li [19] | 2018 | China | Asian | 555/618 | HB | lung cancer | 210 | 250 | 95 | 246 | 305 | 67 | TaqMan | 0.053 |
Abdollahzadeh [15] | 2018 | Iranian | Asian | 150/100 | HB | breast cancer | 116 | 29 | 5 | 86 | 14 | 0 | PCR-RFLP | 0.452 |
Yin [20] | 2018 | China | Asian | 556/395 | HB | lung cancer | 204 | 264 | 88 | 165 | 172 | 58 | TaqMan | 0.232 |